myelopreservation
Showing 1 - 7 of 7
Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)
Active, not recruiting
- Colorectal Cancer Metastatic
- +2 more
- Trilaciclib
- Placebo
-
Tucson, Arizona
- +81 more
Jan 3, 2023
Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)
Not yet recruiting
- Breast Neoplasm
- Trilaciclib plus chemotherapy
- Chemotherapy
- (no location specified)
May 8, 2023
Myelosuppression Adult, Chemotherapeutic Toxicity, Small Cell Lung Cancer Trial (Trilaciclib)
Approved for marketing
- Myelosuppression Adult
- +2 more
- (no location specified)
Mar 17, 2021
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Topotecan)
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Carboplatin)
Terminated
- Small Cell Lung Cancer
- Trilaciclib
- +4 more
-
Beverly Hills, California
- +44 more
Apr 8, 2022
Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)
Terminated
- Triple-Negative Breast Neoplasms
- +3 more
- Trilaciclib
- +2 more
-
Tucson, Arizona
- +53 more
Feb 24, 2022